Format

Send to

Choose Destination
Adv Neurobiol. 2020;24:207-222. doi: 10.1007/978-3-030-30402-7_8.

The Regulation of Reactive Neuroblastosis, Neuroplasticity, and Nutraceuticals for Effective Management of Autism Spectrum Disorder.

Author information

1
School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
2
Laboratory of Stem Cells and Neuroregeneration, Department of Animal Science, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
3
Molecular Gerontology Laboratory, Department of Biochemistry, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
4
School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. janushyas@bdu.ac.in.
5
Molecular Gerontology Laboratory, Department of Biochemistry, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. janushyas@bdu.ac.in.
6
School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. pkmahesh5@gmail.com.
7
Laboratory of Stem Cells and Neuroregeneration, Department of Animal Science, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India. pkmahesh5@gmail.com.
8
Faculty Recharge Programme, University Grants Commission (UGC-FRP), New Delhi, India. pkmahesh5@gmail.com.

Abstract

Autism spectrum disorder (ASD) encompasses a cluster of neurodevelopmental and genetic disorders that has been characterized mainly by social withdrawal, repetitive behavior, restricted interests, and deficits in language processing mainly in children. ASD has been known to severely impair behavioral patterns and cognitive functions including learning and memory due to defects in neuroplasticity. The biology of the ASD appears to be highly complex and heterogeneous, and thus, finding a therapeutic target for autism remains obscure. There has been no complete prevention or disease-modifying cure for this disorder. Recently, individuals with autism have been characterized by reactive neurogenesis, obstructions in axonal growth, heterotopia, resulting from dysplasia of neuroblasts in different brain regions. Therefore, it can be assumed that the aforementioned neuropathological correlates seen in the autistic individuals might originate from the defects mainly in the regulation of neuroblasts in the developing as well as adult brain. Nutrient deficiencies during early brain development and intake of certain allergic foods have been proposed as main reasons for the development of ASD. However, the integrated understanding of neurodevelopment and functional aspects of neuroplasticity working through neurogenesis in ASD is highly limited. Moreover, neurogenesis at the level of neuroblasts can be regulated by nutrition. Hence, defects in neuroblastosis underlying the severity of autism potentially could be rectified by appropriate implementation of nutraceuticals.

KEYWORDS:

Autism; Food and nutrition; Neuroblasts; Neurogenesis; Neuroplasticity; Neurotransmission; Nutraceuticals

Supplemental Content

Loading ...
Support Center